Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research & Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

Vitamin B6 linked to lower lung cancer risk: Above average serum levels of vitamin B6 and methionine can reduce the risk of lung cancer by at least 50 percent, according to a study in the June 14 Journal of the American Medical Association. Scientists with the International Agency for Research on Cancer analyzed the ratios of lung cancer relative to these nutrient levels in smokers, former smokers and nonsmokers enrolled in the European Prospective Investigation into Cancer and Nutrition between 1992 and 2000. After accounting for smoking, they found the higher participants' vitamin B6 and methionine levels were, the lower their risk for lung cancer. However, the researchers did not identify a causal link between higher nutrient levels and reduced cancer risk, nor do they recommend further intervention trials of B vitamins based on results of past vitamin and nutrient intervention trials

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts